RxDoctor Payments Data

Jennifer Proffitt, APRN

Family · Tompkinsville, KYNPI 1760638456

Payments from drug & device makers

$955in general payments, 2019–2025

Across 59 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$186
  • Lilly USA, LLC$124
  • Pfizer$100
  • Novo Nordisk$81
  • Takeda Pharmaceuticals U.S.A., Inc.$69
  • AstraZeneca$52
  • plus $343 from 11 others

What the payments were for

  • Food & beverage$955100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$955 in reported general payments places this provider in the 60th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$4,464
Medicare patients
68
Services billed
207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide38$50,179
FarxigaDapagliflozin Propanediol47$45,495
JardianceEmpagliflozin33$34,045
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$29,117
MounjaroTirzepatide27$26,934
JanuviaSitagliptin Phosphate16$16,159
TrintellixVortioxetine Hydrobromide23$15,285
LinzessLinaclotide12$10,174
ArexvyRsvpref3 Antigen/As01e/Pf23$7,227
Tresiba Flextouch U-100Insulin Degludec15$6,842
Dexlansoprazole DrDexlansoprazole28$4,320
Ondansetron Hcl26$3,612
Metformin Er GastricMetformin Hcl21$2,840
Levothyroxine Sodium115$2,372
Buspirone Hcl75$1,868

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$81$50,17938 claims
AstraZenecaFarxiga$52$45,49547 claims
GSKTrelegy Ellipta, Arexvy$49$36,34456 claims
Lilly USA, LLCMounjaro$124$26,93427 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$69$15,28523 claims
AbbVieLinzess$186$10,17412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,374 family providers in Kentucky.

Other family in Tompkinsville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →